• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖症患者脂肪组织中的 I 型碘甲状腺原氨酸 5'-脱碘酶 mRNA 和活性增加。

Type I iodothyronine 5'-deiodinase mRNA and activity is increased in adipose tissue of obese subjects.

机构信息

Service of Diabetes, Endocrinology and Nutrition (UDEN), Institut d'Investigació Biomèdica de Girona, CIBER de Fisiopatología de Obesidad y Nutrición (CIBERobn, CB06/03/0010), and Instituto de Salud Carlos III, Girona, Spain.

出版信息

Int J Obes (Lond). 2012 Feb;36(2):320-4. doi: 10.1038/ijo.2011.101. Epub 2011 May 24.

DOI:10.1038/ijo.2011.101
PMID:21610697
Abstract

Differentiation and metabolism of adipose tissue are modulated by thyroid hormones (THs), but relatively little is known about the metabolism of THs in this tissue. Expression of the genes for type I iodothyronine 5'-deiodinase (D1), leptin (LEP) and stearoyl-CoA desaturase 1 (SCD-1) was evaluated in omental (OM) and subcutaneous (SC) fat using a cohort of 70 humans. Activities of iodothyronine deiodinases (D1, D2 and D3) were assessed in a randomly selected subpopulation of 19 subjects. D1 expression was upregulated in both OM (P=0.011) and SC (P=0.003) fat of obese subjects. Concomitantly, OM (P=0.002) and SC (P=0.028) LEP expression were increased in obesity, associated with both D1 mRNA (r=0.315, P=0.014) and activity (r=0.647, P=0.023) and inversely related to SCD-1 (r=-0.266, P=0.034) expression in SC fat. Also D1 (but not D2 and D3) activity was increased in OM (∼fourfold, P=0.010) and SC (∼eightfold, P=0.004) fat of obese when compared with non-obese subjects and correlated in both OM (r=0.528, P=0.036) and SC (r=0.749, P=0.005) fat with body mass index. Our results document increased D1 gene expression and activity in adipose tissue of obese humans and suggest a role of 3,5,3'-triiodo-L-thyronine formed by D1 in response to leptin in the modulation of adipose tissue metabolism.

摘要

脂肪组织的分化和代谢受甲状腺激素(THs)调节,但人们对该组织中 THs 的代谢知之甚少。本研究使用 70 名人类的队列评估了腹内(OM)和皮下(SC)脂肪中 I 型碘甲状腺原氨酸 5'-脱碘酶(D1)、瘦素(LEP)和硬脂酰辅酶 A 去饱和酶 1(SCD-1)基因的表达。在随机选择的 19 名受试者亚群中评估了碘甲状腺原氨酸脱碘酶(D1、D2 和 D3)的活性。在肥胖者的 OM(P=0.011)和 SC(P=0.003)脂肪中,D1 表达上调。同时,肥胖者 OM(P=0.002)和 SC(P=0.028)LEP 表达增加,与 D1 mRNA(r=0.315,P=0.014)和活性(r=0.647,P=0.023)呈正相关,与 SC 脂肪中的 SCD-1 表达呈负相关(r=-0.266,P=0.034)。此外,与非肥胖者相比,肥胖者 OM(增加约 4 倍,P=0.010)和 SC(增加约 8 倍,P=0.004)脂肪中的 D1(但不是 D2 和 D3)活性增加,并与 OM(r=0.528,P=0.036)和 SC(r=0.749,P=0.005)脂肪中的体重指数相关。我们的研究结果记录了肥胖人群脂肪组织中 D1 基因表达和活性增加,并表明 D1 形成的 3,5,3'-三碘-L-甲状腺素在响应瘦素调节脂肪组织代谢中的作用。

相似文献

1
Type I iodothyronine 5'-deiodinase mRNA and activity is increased in adipose tissue of obese subjects.肥胖症患者脂肪组织中的 I 型碘甲状腺原氨酸 5'-脱碘酶 mRNA 和活性增加。
Int J Obes (Lond). 2012 Feb;36(2):320-4. doi: 10.1038/ijo.2011.101. Epub 2011 May 24.
2
Thyroid hormone responsive Spot 14 increases during differentiation of human adipocytes and its expression is down-regulated in obese subjects.甲状腺激素反应性 Spot14 在人类脂肪细胞分化过程中增加,而在肥胖患者中其表达水平下调。
Int J Obes (Lond). 2010 Mar;34(3):487-99. doi: 10.1038/ijo.2009.263. Epub 2009 Dec 22.
3
Modulation of type I iodothyronine 5'-deiodinase activity in white adipose tissue by nutrition: possible involvement of leptin.营养对白色脂肪组织中I型碘甲状腺原氨酸5'-脱碘酶活性的调节:瘦素可能参与其中。
Physiol Res. 2010;59(4):561-569. doi: 10.33549/physiolres.931866. Epub 2009 Nov 20.
4
The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects.肥胖患者内脏脂肪组织中主要脂肪生成酶的基因表达下调。
Obesity (Silver Spring). 2010 Jan;18(1):13-20. doi: 10.1038/oby.2009.202. Epub 2009 Jun 18.
5
Presence and regulation of D1 and D2 deiodinases in rat white adipose tissue.大鼠白色脂肪组织中 D1 和 D2 脱碘酶的存在与调节。
Metabolism. 2011 Sep;60(9):1207-10. doi: 10.1016/j.metabol.2011.01.014. Epub 2011 Mar 11.
6
Subcutaneous fat shows higher thyroid hormone receptor-alpha1 gene expression than omental fat.皮下脂肪的甲状腺激素受体-α1 基因表达高于网膜脂肪。
Obesity (Silver Spring). 2009 Dec;17(12):2134-41. doi: 10.1038/oby.2009.110. Epub 2009 Apr 9.
7
Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.儿童和成人脂肪组织中11β-羟类固醇脱氢酶1型和瘦素的特定储存库信使核糖核酸表达
Int J Obes (Lond). 2007 May;31(5):820-8. doi: 10.1038/sj.ijo.0803470. Epub 2006 Oct 24.
8
Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endochondral ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate.甲状腺激素可促进小鼠ATDC5细胞中的软骨细胞分化,并通过生长板中的碘甲状腺原氨酸脱碘酶刺激胎鼠胫骨的软骨内成骨。
J Bone Miner Res. 2002 Mar;17(3):443-54. doi: 10.1359/jbmr.2002.17.3.443.
9
Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans.肥胖人群网膜与腹部皮下脂肪组织中瘦素信使核糖核酸水平的差异
Horm Metab Res. 1996 Dec;28(12):690-3. doi: 10.1055/s-2007-979879.
10
The effect of 3,5,3'-triiodothyronine supplementation on zebrafish (Danio rerio) embryonic development and expression of iodothyronine deiodinases and thyroid hormone receptors.补充3,5,3'-三碘甲状腺原氨酸对斑马鱼(Danio rerio)胚胎发育及碘甲状腺原氨酸脱碘酶和甲状腺激素受体表达的影响
Gen Comp Endocrinol. 2007 Jun-Jul;152(2-3):206-14. doi: 10.1016/j.ygcen.2007.02.020. Epub 2007 Feb 27.

引用本文的文献

1
The impact of weight loss interventions on thyroid function: a systematic review and meta-analysis.体重减轻干预对甲状腺功能的影响:一项系统评价和荟萃分析。
Ann Med Surg (Lond). 2025 May 26;87(7):4484-4497. doi: 10.1097/MS9.0000000000003428. eCollection 2025 Jul.
2
Circulating leptin levels in thyroid dysfunction: a systematic review and meta-analysis.甲状腺功能障碍患者的循环瘦素水平:一项系统评价和荟萃分析。
BMC Endocr Disord. 2025 Jun 6;25(1):140. doi: 10.1186/s12902-025-01943-y.
3
Impaired sensitivity to thyroid hormones is associated with increased body fat mass/muscle mass ratio (F/M) in the euthyroid population.
甲状腺激素敏感性受损与甲状腺功能正常人群的体脂量/肌肉量比值(F/M)升高有关。
Diabetol Metab Syndr. 2025 Apr 15;17(1):128. doi: 10.1186/s13098-025-01693-w.
4
When Should the Treatment of Obesity in Thyroid Disease Begin?甲状腺疾病中的肥胖治疗应何时开始?
Biomedicines. 2025 Jan 10;13(1):157. doi: 10.3390/biomedicines13010157.
5
Elevated thyroid autoantibodies as risk factors for metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus.甲状腺自身抗体升高作为2型糖尿病患者代谢功能障碍相关脂肪性肝病的危险因素
Front Endocrinol (Lausanne). 2024 Dec 5;15:1478818. doi: 10.3389/fendo.2024.1478818. eCollection 2024.
6
Association between hypothyroidism and metabolic syndrome in Qinghai, China.中国青海地区甲状腺功能减退症与代谢综合征的相关性。
Front Endocrinol (Lausanne). 2024 Oct 25;15:1407996. doi: 10.3389/fendo.2024.1407996. eCollection 2024.
7
Metabolic Syndrome, Thyroid Dysfunction, and Cardiovascular Risk: The Triptych of Evil.代谢综合征、甲状腺功能障碍与心血管风险:邪恶的三重奏。
Int J Mol Sci. 2024 Oct 2;25(19):10628. doi: 10.3390/ijms251910628.
8
Impaired Sensitivity to Thyroid Hormones is Associated with Central Obesity in Euthyroid Type 2 Diabetes Mellitus Patients with Overweight and Obesity.甲状腺激素敏感性受损与超重和肥胖的甲状腺功能正常的2型糖尿病患者的中心性肥胖有关。
Diabetes Metab Syndr Obes. 2024 Sep 11;17:3379-3396. doi: 10.2147/DMSO.S472550. eCollection 2024.
9
Total weight loss induces the alteration in thyroid function after bariatric surgery.体重减轻会导致减重手术后甲状腺功能的改变。
Front Endocrinol (Lausanne). 2024 Jan 30;15:1333033. doi: 10.3389/fendo.2024.1333033. eCollection 2024.
10
Subclinical Hypothyroidism in Patients with Obesity and Metabolic Syndrome: A Narrative Review.肥胖合并代谢综合征患者的亚临床甲状腺功能减退症:一篇叙述性综述。
Nutrients. 2023 Dec 27;16(1):87. doi: 10.3390/nu16010087.